We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
-4.79%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$5.12B
AUM Growth
-$345M
Cap. Flow
-$36.9M
Cap. Flow %
-0.72%
Top 10 Hldgs %
29.77%
Holding
386
New
7
Increased
134
Reduced
131
Closed
16

Top Buys

Rank Stock Value
1
AOS icon
A.O. Smith
AOS
+$3.37M
2
AAPL icon
Apple
AAPL
+$1.98M
3
AMZN icon
Amazon
AMZN
+$1.74M
4
NEE icon
NextEra Energy
NEE
+$1.7M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.56M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$28.4M
2
BALL icon
Ball Corp
BALL
+$4.2M
3
META icon
Meta Platforms (Facebook)
META
+$3.17M
4
INTC icon
Intel
INTC
+$2.2M
5
PFF icon
iShares Preferred and Income Securities ETF
PFF
+$2.04M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Healthcare 20.53%
3 Consumer Discretionary 12.15%
4 Financials 11.63%
5 Consumer Staples 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GL icon
326
Globe Life
GL
$14.1B
$289K 0.01%
2,900
– –
APA icon
327
APA Corp
APA
$12.8B
$286K 0.01%
8,350
-2,250
-21% -$80.4K
MOAT icon
328
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
$286K 0.01%
4,781
– –
VDE icon
329
Vanguard Energy ETF
VDE
$9.89B
$279K 0.01%
2,745
– –
SLF icon
330
Sun Life Financial
SLF
$45.8B
$278K 0.01%
6,977
– –
FLRN icon
331
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.08B
$273K 0.01%
9,000
– –
LGND icon
332
Ligand Pharmaceuticals
LGND
$5.78B
$271K 0.01%
5,049
-1,243
-20% -$73.1K
NTAP icon
333
NetApp
NTAP
$34.3B
$269K 0.01%
4,344
– –
SRE icon
334
Sempra
SRE
$58.5B
$269K 0.01%
3,596
+570
+19% +$46.1K
MMP
335
DELISTED
Magellan Midstream Partners, L.P.
MMP
$267K 0.01%
5,622
– –
IGIB icon
336
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.4B
$266K 0.01%
5,520
-100
-2% -$5.11K
LDOS icon
337
Leidos
LDOS
$14B
$266K 0.01%
3,050
– –
FXH icon
338
First Trust Health Care AlphaDEX Fund
FXH
$1.03B
$264K 0.01%
2,717
– –
IBB icon
339
iShares Biotechnology ETF
IBB
$9.28B
$264K 0.01%
2,257
– –
LNC icon
340
Lincoln National
LNC
$8.7B
$263K 0.01%
6,000
– –
QTEC icon
341
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.48B
$261K 0.01%
2,493
– –
KNSL icon
342
Kinsale Capital Group
KNSL
$8.11B
$255K 0.01%
1,000
– –
PEG icon
343
Public Service Enterprise Group
PEG
$38.5B
$249K ﹤0.01%
4,435
– –
YUM icon
344
Yum! Brands
YUM
$42.2B
$247K ﹤0.01%
2,319
-15
-0.6% -$1.74K
SMG icon
345
ScottsMiracle-Gro
SMG
$3.94B
$241K ﹤0.01%
5,650
-5,967
-51% -$428K
TWTR
346
DELISTED
Twitter, Inc.
TWTR
$241K ﹤0.01%
5,500
– –
SU icon
347
Suncor Energy
SU
$78.6B
$238K ﹤0.01%
8,472
-480
-5% -$15.2K
VFC icon
348
VF Corp
VFC
$5.76B
$238K ﹤0.01%
7,941
– –
HUBS icon
349
HubSpot
HUBS
$11.9B
$233K ﹤0.01%
863
+82
+10% +$26K
VTEB icon
350
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$232K ﹤0.01%
4,808
– –
12 13
14
15 16

Similar funds

OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Welch & Forbes's Q3 2022 Portfolio in Review

As of Q3 2022, Welch & Forbes held 386 positions worth $5.12B, down 6.3% from $5.47B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Welch & Forbes's Q3 2022 filing shows 7 new, 134 increased, 131 reduced and 16 closed positions. Its largest new stake was Vanguard High Dividend Yield ETF: 6,616 shares worth $628K. The largest sale was GSK, an estimated $28.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Welch & Forbes's largest Q3 2022 buy was Vanguard High Dividend Yield ETF: 6,616 shares worth $628K.
  • Welch & Forbes added most to A.O. Smith in Q3 2022, an estimated $3.37M increase.
  • Welch & Forbes's biggest Q3 2022 reduction was Ball Corp, cutting an estimated $4.2M.
  • Welch & Forbes fully exited GSK in Q3 2022, selling an estimated $28.4M.
  • Welch & Forbes's ten largest holdings make up 30% of its $5.12B portfolio in Q3 2022.
  • Welch & Forbes opened 7 new positions and closed 16 in Q3 2022.
  • Welch & Forbes's portfolio value fell 6.3% quarter-over-quarter to $5.12B.

Based on Welch & Forbes's 13F filing for Q3 2022, filed 31 Oct 2022.